Accelerator-based Neutron Brachytherapy

Information

  • Research Project
  • 6483979
  • ApplicationId
    6483979
  • Core Project Number
    R43CA096358
  • Full Project Number
    1R43CA096358-01
  • Serial Number
    96358
  • FOA Number
  • Sub Project Id
  • Project Start Date
    4/25/2002 - 22 years ago
  • Project End Date
    3/31/2005 - 19 years ago
  • Program Officer Name
    DEYE, JAMES
  • Budget Start Date
    4/25/2002 - 22 years ago
  • Budget End Date
    3/31/2005 - 19 years ago
  • Fiscal Year
    2002
  • Support Year
    1
  • Suffix
  • Award Notice Date
    4/25/2002 - 22 years ago
Organizations

Accelerator-based Neutron Brachytherapy

The development of a novel treatment of head and neck tumors based on fast neuron brachytherapy, with or without dose augmentation by neutron by neutron capture in boron, it is proposed. Use of brachytherapy approach rather than external beam irradiation will allow intracavity delivery of neutrons leading to vastly improved tumor to healthy tissue dose ratios. Significant healthy tissue sparing should allow the delivery of larger tumor doses than those delivered using external beams, and larger tumor doses would, in turn, lead to improved local control. Unlike the case with many cancer types in which patients die of distant metastases, patients with head and neck tumors tend to die of local and regional involvement. Thus, improving local control is expected to lead to improved patient survival. Accelerator-based neutron brachytherapy would involve the insertion into a patient cavity or tumor of a long, narrow accelerator tube having a neutron-producing target at the tip. In Phase I, a computational model of neutron transport in the human head and neck will be developed and used to determine the most effective neutron source parameters for irradiation of head and neck tumors. The dose characteristics of fast neutron brachytherapy will be evaluated relative to external beam fast neutron therapy, and the potential tumor dose enhancement provided by boron neutron capture will be quantified. Finally, the engineering requirements for a clinically useful accelerator-based neutron brachytherapy source will be determine. PROPOSED COMMERCIAL APPLICATIONS: If neutron brachytherapy is found to provide significant advantages for the treatment of head and neck tumors, then a market will exist for brachytherapy systems. Head and neck cancers account for 5-6% of all cancers in the U.S., and as high as 50% of cancers in developing countries. Neutron brachytherapy may also prove useful in the treatment of other prevalent cancers, such as prostate cancer. An accelerator-based brachytherapy system could be made compact enough to be installed and operated at major medical centers.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R43
  • Administering IC
    CA
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    129329
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    395
  • Ed Inst. Type
  • Funding ICs
    NCI:129329\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NEWTON SCIENTIFIC, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02141
  • Organization District
    UNITED STATES